Bangor University has secured national recognition for endeavor clinical trials and studies of the very best quality.
The North Wales Organisation for irregular Trials in Health (& Social Care) (NWORTH), the trials unit within the Institute of Medical & Social Care analysis (IMSCaR) within the school of Health and behavioral Sciences (CoHaBS) has been across the country recognised by the united kingdom Clinical analysis Collaboration (UKCRC) as a totally registered Clinical Trials Unit (CTU) for analysis excellence in endeavor multi centre clinical trials and different neat studies.
Professor Jo Rycroft-Malone, University Director of analysis, Deputy Vice-Chancellor for analysis & Enterprise\'s workplace aforesaid “NWORTH\'s re-registration is testimony to the standard of the work they need undertaken and therefore the processes they need established to deliver sturdy across the country and internationally recognised analysis. Health and medical analysis could be a key part of Bangor University\'s analysis strategy and therefore the continued success of the trial unit helps the university deliver on this agenda with our partners in Betsi Cadwaladr University Health Board. UKCRC\'s vote of confidence in NWORTH\'s work can guarantee they\'re going from strength to strength in delivering analysis that has the potential to boost the health of the local people and on the far side.”
Professor Bob Woods, Acting Head of IMSCaR commented that “we square measure lucky to own an excellent deal of experience in North Wales within the analysis of complicated health care interventions, and this recognition of the Trials Unit confirms Bangor as a number one centre for this work.”
Rhiannon Whitaker, NWORTH’s Associate Scientific Director aforesaid “we square measure delighted that our exertions in supporting the united kingdom wide studies has been recognised as warrant full registration below the UKCRC’s internationally recognised method. Our registered standing offers support to clinicians, participants and funders alike that analysis emanating from our unit is of the very best quality.”
To obtain full UKCRC registered standing, NWORTH was needed to demonstrate a diary and skill of coordinating multi-centre irregular controlled trials, a core team of skilled employees to develop studies, a sturdy quality assurance systems and processes to satisfy acceptable rules and legislation and proof of longer-term viability of capability for trials coordination and therefore the development/maintenance of a trials portfolio.
The international UKCRC review committee noted that “the unit given a well made and thought of application that provided clear proof of established operational expertise within the style and delivery of huge scale multicentre clinical trials supported by a powerful set of publications.... a powerful application ..... that met the standards for full registration.”
The North Wales Organisation for irregular Trials in Health (& Social Care) (NWORTH), the trials unit within the Institute of Medical & Social Care analysis (IMSCaR) within the school of Health and behavioral Sciences (CoHaBS) has been across the country recognised by the united kingdom Clinical analysis Collaboration (UKCRC) as a totally registered Clinical Trials Unit (CTU) for analysis excellence in endeavor multi centre clinical trials and different neat studies.
Professor Jo Rycroft-Malone, University Director of analysis, Deputy Vice-Chancellor for analysis & Enterprise\'s workplace aforesaid “NWORTH\'s re-registration is testimony to the standard of the work they need undertaken and therefore the processes they need established to deliver sturdy across the country and internationally recognised analysis. Health and medical analysis could be a key part of Bangor University\'s analysis strategy and therefore the continued success of the trial unit helps the university deliver on this agenda with our partners in Betsi Cadwaladr University Health Board. UKCRC\'s vote of confidence in NWORTH\'s work can guarantee they\'re going from strength to strength in delivering analysis that has the potential to boost the health of the local people and on the far side.”
Professor Bob Woods, Acting Head of IMSCaR commented that “we square measure lucky to own an excellent deal of experience in North Wales within the analysis of complicated health care interventions, and this recognition of the Trials Unit confirms Bangor as a number one centre for this work.”
Rhiannon Whitaker, NWORTH’s Associate Scientific Director aforesaid “we square measure delighted that our exertions in supporting the united kingdom wide studies has been recognised as warrant full registration below the UKCRC’s internationally recognised method. Our registered standing offers support to clinicians, participants and funders alike that analysis emanating from our unit is of the very best quality.”
To obtain full UKCRC registered standing, NWORTH was needed to demonstrate a diary and skill of coordinating multi-centre irregular controlled trials, a core team of skilled employees to develop studies, a sturdy quality assurance systems and processes to satisfy acceptable rules and legislation and proof of longer-term viability of capability for trials coordination and therefore the development/maintenance of a trials portfolio.
The international UKCRC review committee noted that “the unit given a well made and thought of application that provided clear proof of established operational expertise within the style and delivery of huge scale multicentre clinical trials supported by a powerful set of publications.... a powerful application ..... that met the standards for full registration.”